TrialThe journal of headache and pain2021

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study.

Antoinette MaassenVanDenBrink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.